Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
about
Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.Staging of biliary tract and primary liver tumors.Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcomePrognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinomaEvaluation of the new AJCC staging system for resectable hepatocellular carcinomaChoice of approach for hepatectomy for hepatocellular carcinoma located in the caudate lobe: isolated or combined lobectomy?Model to estimate survival in ambulatory patients with hepatocellular carcinoma.Obesity and microvascular invasion in hepatocellular carcinoma.Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma.Advanced hepatocellular carcinoma: which staging systems best predict prognosis?Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinomaHepatocellular carcinoma: A global view.Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience.Staging systems: Is there a surgical staging and a medical one? A surgeon's perspective.Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma.What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?Radiofrequency ablation of high-grade dysplastic nodules.Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?Accomplishments in 2007 in the management of hepatobiliary cancers.Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study
P2860
Q33716318-F1440007-3173-4498-BB9C-0E160C170958Q33773415-59DD7167-60D0-4399-85C3-1192F647BB02Q34207805-D8F90306-BF1B-4979-BF2A-F1C2F9F580D1Q34446810-E44BD7F3-38F6-4D53-BDDE-7017987B57D3Q34504657-29B7F043-2268-43F3-A2E8-6C3EADE38712Q35113002-3A7BB119-B901-4DE7-B9D7-D1E56198D08FQ35114970-265CB6C2-C67B-4289-A460-50F8F0FE0417Q35301805-CB607D8C-5F66-487B-8FB5-D9BCA86FA06FQ35431693-A06900CA-C5D1-4AFF-AD08-107CF2168BE8Q36144524-9ACE09AF-AE0B-4633-ACC7-47AE07320ADDQ36588117-E6CB0D34-A481-41B4-8B4D-5F2A055D41E9Q36708755-38B37B47-AB4B-4EA5-AAE6-7B8F25E44BA6Q36808144-18D159AA-816D-40B7-80CD-6A76FBCE30B2Q36836103-500DEF64-3CBD-4375-8A0A-AB1EA87AF3BCQ37375773-96E2C985-E8F4-4B3E-A7ED-0B583E1464C3Q37430985-760C033A-16F8-4C4A-9C14-5B15D5BA5F3BQ37582059-C6BFC6F7-7DE7-4A6C-923F-D6EC3CE6CA07Q37589349-CAF234FE-DD83-42FB-A319-E998391EEA0DQ37598640-F8812D2F-1ADA-4493-A8DE-C41CE0FBB011Q37625925-10CB67C2-6ABC-4660-AB90-F4E22572B366Q37783346-6635E943-61C6-4ABF-9960-B24F6009C890Q37886890-DE17FAA2-BC4E-4568-AA19-DB9C52858113Q37910079-F5C635D9-B256-4799-B03D-D3E070B33D73Q38057714-C5BF39B9-55DD-4872-9309-8477F5A03816Q42004327-408EA00B-EA86-42A6-B62C-A160B2259DDAQ44215564-9D9EDEA6-D96E-4B28-AD3F-F0A79C2846ECQ45166388-BBA8DA52-5788-4712-AE4D-FC0FB5019C26Q54485235-04AC9E97-5C89-4D4D-B689-C6F2C339805FQ55092099-FC98DB9B-EC84-4C7D-88E5-79DFB3AAABC8Q57816129-11A89901-5256-4A14-93ED-7FBCAC11283A
P2860
Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Prognostic value and clinical ...... able hepatocellular carcinoma.
@en
Prognostic value and clinical ...... able hepatocellular carcinoma.
@nl
type
label
Prognostic value and clinical ...... able hepatocellular carcinoma.
@en
Prognostic value and clinical ...... able hepatocellular carcinoma.
@nl
prefLabel
Prognostic value and clinical ...... able hepatocellular carcinoma.
@en
Prognostic value and clinical ...... able hepatocellular carcinoma.
@nl
P2093
P1476
Prognostic value and clinical ...... able hepatocellular carcinoma.
@en
P2093
Che-Chuan Loong
Chew-Wun Wu
Gar-Yang Chau
Hao-Jan Lei
Kuang-Liang King
Shyh-Haw Tsay
Wing-Yiu Lui
P304
P356
10.1016/J.JAMCOLLSURG.2006.06.030
P577
2006-08-23T00:00:00Z